London · Delayed Price · Currency is GBP · Price in GBX Molecule Group Statistics
Total Valuation
Molecule Group has a market cap or net worth of GBP 58.64 million. The enterprise value is 54.46 million.
| Market Cap | 58.64M |
| Enterprise Value | 54.46M |
Important Dates
The next estimated earnings date is Thursday, December 24, 2026.
| Earnings Date | Dec 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Molecule Group has 27.28 million shares outstanding. The number of shares has increased by 1,539.68% in one year.
| Current Share Class | 27.28M |
| Shares Outstanding | 27.28M |
| Shares Change (YoY) | +1,539.68% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.58% |
| Owned by Institutions (%) | 65.71% |
| Float | 13.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 53.75 |
| PS Ratio | 5.84 |
| PB Ratio | 1.33 |
| P/TBV Ratio | 1,688.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.63 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.21 |
| Interest Coverage | -99.37 |
Financial Efficiency
Return on equity (ROE) is -24.27% and return on invested capital (ROIC) is -6.92%.
| Return on Equity (ROE) | -24.27% |
| Return on Assets (ROA) | -5.55% |
| Return on Invested Capital (ROIC) | -6.92% |
| Return on Capital Employed (ROCE) | -5.04% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.67M |
| Profits Per Employee | -891,014 |
| Employee Count | 6 |
| Asset Turnover | 0.35 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Molecule Group has paid 137,329 in taxes.
| Income Tax | 137,329 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.47% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -13.47% |
| 50-Day Moving Average | 210.95 |
| 200-Day Moving Average | 234.55 |
| Relative Strength Index (RSI) | 63.77 |
| Average Volume (20 Days) | 20,368 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Molecule Group had revenue of GBP 10.03 million and -5.35 million in losses. Loss per share was -0.42.
| Revenue | 10.03M |
| Gross Profit | 2.16M |
| Operating Income | -2.53M |
| Pretax Income | -5.21M |
| Net Income | -5.35M |
| EBITDA | n/a |
| EBIT | -2.53M |
| Loss Per Share | -0.42 |
Balance Sheet
The company has 5.69 million in cash and 1.51 million in debt, with a net cash position of 4.18 million or 0.15 per share.
| Cash & Cash Equivalents | 5.69M |
| Total Debt | 1.51M |
| Net Cash | 4.18M |
| Net Cash Per Share | 0.15 |
| Equity (Book Value) | 44.25M |
| Book Value Per Share | 1.62 |
| Working Capital | 4.29M |
Cash Flow
In the last 12 months, operating cash flow was -7.17 million and capital expenditures -65,961, giving a free cash flow of -7.23 million.
| Operating Cash Flow | -7.17M |
| Capital Expenditures | -65,961 |
| Depreciation & Amortization | 49,198 |
| Net Borrowing | -1.70M |
| Free Cash Flow | -7.23M |
| FCF Per Share | -0.27 |
Margins
Gross margin is 21.52%, with operating and profit margins of -25.22% and -53.28%.
| Gross Margin | 21.52% |
| Operating Margin | -25.22% |
| Pretax Margin | -51.91% |
| Profit Margin | -53.28% |
| EBITDA Margin | n/a |
| EBIT Margin | -25.22% |
| FCF Margin | n/a |
Dividends & Yields
Molecule Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1,539.68% |
| Shareholder Yield | -1,539.68% |
| Earnings Yield | -9.12% |
| FCF Yield | -12.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Molecule Group has an Altman Z-Score of 1.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.54 |
| Piotroski F-Score | 1 |